These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22383046)

  • 21. Psychotherapeutic medication patterns for youths with attention-deficit/hyperactivity disorder.
    Zito JM; Safer DJ; dosReis S; Magder LS; Gardner JF; Zarin DA
    Arch Pediatr Adolesc Med; 1999 Dec; 153(12):1257-63. PubMed ID: 10591302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychotropic medications prescribing patterns for children and adolescents in New York's public mental health system.
    Lyons JS; MacIntyre JC; Lee ME; Carpinello S; Zuber MP; Fazio ML
    Community Ment Health J; 2004 Apr; 40(2):101-18. PubMed ID: 15206636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Annotation: The use of psychotropic medications in children: a British view.
    Bramble D
    J Child Psychol Psychiatry; 2003 Feb; 44(2):169-79. PubMed ID: 12587854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulant Treatment of Young People in the United States.
    Olfson M; King M; Schoenbaum M
    J Child Adolesc Psychopharmacol; 2016 Aug; 26(6):520-6. PubMed ID: 26982632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decrease in Statewide Antipsychotic Prescribing after Implementation of Child and Adolescent Psychiatry Consultation Services.
    Barclay RP; Penfold RB; Sullivan D; Boydston L; Wignall J; Hilt RJ
    Health Serv Res; 2017 Apr; 52(2):561-578. PubMed ID: 28297075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prescribing of psychotropic medications for children by Australian pediatricians and child psychiatrists.
    Efron D; Hiscock H; Sewell JR; Cranswick NE; Vance AL; Tyl Y; Luk ES
    Pediatrics; 2003 Feb; 111(2):372-5. PubMed ID: 12563066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hospital surveys of prescribing practices with psychotherapeutic drugs. A critical examination.
    Prien RF; Balter MB; Caffey EM
    Arch Gen Psychiatry; 1978 Oct; 35(10):1271-5. PubMed ID: 567966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. First-year Medicare Part D prescription drug benefits: medication access and continuity among dual eligible psychiatric patients.
    West JC; Wilk JE; Rae DS; Muszynski IL; Rubio-Stipec M; Alter CL; Sanders KE; Crystal S; Regier DA
    J Clin Psychiatry; 2010 Apr; 71(4):400-10. PubMed ID: 19925748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of psychotropic medications in general paediatric practice.
    Hazell P
    J Paediatr Child Health; 2018 Oct; 54(10):1073-1076. PubMed ID: 30294990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychopharmaceutical Prescription Monitoring for Children in the Child Welfare System.
    Raman R; Jarrett RT; Cull MJ; Gracey K; Shaffer AM; Epstein RA
    Psychiatr Serv; 2021 Mar; 72(3):295-301. PubMed ID: 33467871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current psychotropic medication prescribing patterns in late-life bipolar disorder.
    Rej S; Herrmann N; Shulman K; Fischer HD; Fung K; Gruneir A
    Int J Geriatr Psychiatry; 2017 Dec; 32(12):1459-1465. PubMed ID: 27911003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Update on Psychotropic Drug Prescribing in the United States: 2014-2015.
    Greenblatt DJ; Harmatz JS; Shader RI
    J Clin Psychopharmacol; 2018 Feb; 38(1):1-4. PubMed ID: 29215384
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacotherapy for the treatment of aggression in pediatric and adolescent patients with autism spectrum disorder comorbid with attention-deficit hyperactivity disorder: A questionnaire survey of 571 psychiatrists.
    Yamamuro K; Tsujii N; Ota T; Kishimoto T; Iida J
    Psychiatry Clin Neurosci; 2017 Aug; 71(8):554-561. PubMed ID: 28317224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Childhood Attention-Deficit/Hyperactivity Disorder Prescribing by Prescriber Type and Specialty in Oregon Medicaid.
    Klein TA; Panther S; Woo T; Odom-Maryon T; Daratha K
    J Child Adolesc Psychopharmacol; 2016 Aug; 26(6):548-54. PubMed ID: 27135134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retrospective analysis of community pharmacists' recommendations in the North Carolina Medicaid medication therapy management program.
    Michaels NM; Jenkins GF; Pruss DL; Heidrick JE; Ferreri SP
    J Am Pharm Assoc (2003); 2010; 50(3):347-53. PubMed ID: 20452907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychotherapeutic medication prevalence in Medicaid-insured preschoolers.
    Zito JM; Safer DJ; Valluri S; Gardner JF; Korelitz JJ; Mattison DR
    J Child Adolesc Psychopharmacol; 2007 Apr; 17(2):195-203. PubMed ID: 17489714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. For what diagnoses are psychotropic medications being prescribed?: a nationally representative survey of physicians.
    Mark TL
    CNS Drugs; 2010 Apr; 24(4):319-26. PubMed ID: 20297856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uptake of electronic prescribing in community-based practices.
    Fischer MA; Vogeli C; Stedman MR; Ferris TG; Weissman JS
    J Gen Intern Med; 2008 Apr; 23(4):358-63. PubMed ID: 18373130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prescription of psychotropic medications to youths in office-based practice.
    Goodwin R; Gould MS; Blanco C; Olfson M
    Psychiatr Serv; 2001 Aug; 52(8):1081-7. PubMed ID: 11474055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders.
    Mandell DS; Morales KH; Marcus SC; Stahmer AC; Doshi J; Polsky DE
    Pediatrics; 2008 Mar; 121(3):e441-8. PubMed ID: 18310165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.